Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04933812 · ClinicalTrials.gov registry record · NA
EngagINg the COmmunity to Reduce Preterm Birth Via Adherence To an Individualized Prematurity Prevention Plan
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT04933812 is a NA study that has completed, run by Duke University. The registered enrollment target is 31 participants.
The verdict
NCT04933812, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if INCORPorATe IP3 is feasible prior to a larger trial focused on determining efficacy. Feasibility will be measured using the RE-AIM framework4: Reach or Participation (Primary Outcome): (a) percent of eligible participants who are successfully recruited and attend at least one group session; Effectiveness: retention rate in the intervention; Implementation: fidelity to the intervention protocol; Maintenance: intervention sustainability based on continued engagement from the participants.
Interventions
- BEHAVIORAL Facebook discussions and Virtual group meetings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2022-10-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04933812
The ClinicalTrials.gov registry entry for NCT04933812 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Facebook discussions and Virtual group meetings is the first listed.
NCT04933812 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04933812 about?
NCT04933812 is a clinical study titled "EngagINg the COmmunity to Reduce Preterm Birth Via Adherence To an Individualized Prematurity Prevention Plan". The purpose of this study is to determine if INCORPorATe IP3 is feasible prior to a larger trial focused on determining efficacy. Feasibility will be measured using the RE-AIM framework4: Reach or Participation (Primary Outcome): (a) percent of eligible participants who are successfully recruited an...
What is the current status of trial NCT04933812?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2021-06-21. Estimated completion is 2022-10-14.
What interventions are being tested in trial NCT04933812?
The interventions under investigation include: Facebook discussions and Virtual group meetings (BEHAVIORAL).
Who is sponsoring clinical trial NCT04933812?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.